During pregnancy, the umbilical cord functions as a lifeline between mother and child. After a baby’s delivery, the cord blood present in the umbilical cord can be preserved which can treat the family for over 80 Life Threatening diseases. Here is a list of treatable diseases through Cord Blood Banking.
Immediately after the delivery of your baby, the cord is clamped and your baby separated from the cord and moved from the birthing area. The doctor then collects the umbilical cord blood by inserting a needle into the cord vein, and draining the blood into a blood bag. This procedure is painless and risk-free.
In 2013, Cordlife India successfully attained accreditation from AABB, world’s gold standard in private cord blood banking.
We guarantee that your baby's cord blood unit will be screened, processed and stored according to the strictest international quality assurance programme which are preferred by Transplant surgeons.
With CellOptima™, you will receive the following assurances:
All patents granted for CellOptima™ prevents other companies from harvesting stem cells from cord lining. CellOptima™ is only available at Cordlife in India.
We offer Sepax®2 automated processing technology, a Swiss-made and U.S. FDA-cleared Personalized Processing Instrument which can recover as high as 99.46% of Total Nucleated Cells from cord blood; up to 57% higher cell count higher than other processing methods. It is also a functionally closed processing system which ensures the sterility of the cord blood by eliminating exposure to air contaminants and also cross contamination.
Cordlife uses the U.S. FDA approved cryogenic storage pouch. This multi-compartmentalised cryobag has 20 percent and 80 percent compartments. This dual compartment enables stem cell expansion in future. That means that when this stem cell expansion technology is commercially viable, you can withdraw 80 percent of the stem cells for immediate use /treatment while continuing to store the balance for later expansion.
Moinam
Moinam was diagnosed Thalassemia when he was barely one year old. If left untreated, most of the children inflicted with this disorder do not live beyond the age of 10. Fortuitously, his newborn sister was free from Thalassemia and her cord blood stem cells were a perfect match for Moinam, with small amount of bone marrow to supplement the transplant, Moinam is now in his recovery phase.
"We decided to use a mixture of bone marrow and cord blood cells as it has a better and faster chance of success than only bone marrow cells. Bone marrow stem cells, on the other hand, could lead to Graft Versus Host Disease, triggered by the body's defense mechanism while the transfusion is being done. Not only increase the stem cell count, but also reduce the chance of any complications. It is the treatment of choice in such cases and leads to a complete cure," explained Dr Mukherjee, Medical Director of Netaji Subhash Chandra Bose Cancer Research Institute.